Restless Legs Syndrome in Temporomandibular Joint Disorders
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Trial details
- Who runs it
- Gulseren Demir Karakilic
- Trial code
- NCT07292077
- Record updated
- 29 December 2025
- Original description
This observational, cross-sectional, descriptive study aims to evaluate the prevalence of restless legs syndrome in patients with temporomandibular joint dysfunction and to investigate its effects on sleep quality and health-related quality of life. The study will be conducted in the otolaryngology outpatient clinic of Gaziantep City Hospital, Türkiye.Read full original descriptionShow less
Frequency of Restless Legs Syndrome in Patients With Temporomandibular Joint Disorders and Its Effect on Sleep Quality
This observational, cross-sectional, descriptive study aims to evaluate the prevalence of restless legs syndrome in patients with temporomandibular joint dysfunction and to investigate its effects on sleep quality and health-related quality of life. The study will be conducted in the otolaryngology outpatient clinic of Gaziantep City Hospital, Türkiye.
Adults aged 18 to 65 years who are clinically diagnosed with temporomandibular joint dysfunction and meet the inclusion criteria will be invited to participate. An age- and sex-matched control group consisting of individuals without temporomandibular joint dysfunction will also be recruited.
All participants will undergo face-to-face structured interviews during which standardized and validated questionnaires will be administered. The study will collect sociodemographic data, clinical characteristics, and responses to validated assessment tools measuring mandibular function, anxiety and depression symptoms, restless legs syndrome, sleep quality, and health-related quality of life.
Inclusion: Adults aged 18 to 65 years; For the patient group: clinical diagnosis of temporomandibular joint disorder; Cognitively intact and able to understand study procedures; Literate and able to complete self-report questionnaires; Willing to participate and provided written informed consent.
Exclusion: Current use of medications that may influence sleep or motor function; Presence of neurological or psychiatric disorders; Cognitive impairment that interferes with questionnaire completion; Systemic diseases that may affect sleep or motor function; Refusal or inability to provide informed consent.